Clinical trial PYX-201-101
Phase 1, First-in-Human, Open-label, Multicenter Study Evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PYX-201 in subjects with advanced solid tumors (PYX-201-101)
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Pyxis Oncology |
| EudraCT Identifier | 2022-002284-30 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05720117 |
| Last update |